The current study examines the hypothesis that a survival signal from AKT activation is mediated by NF-κB and subsequent transcriptional regulation of BCL-2 gene family members; furthermore, inhibition of this pathway sensitises pancreatic cancer cells to the apoptotic effect of gemcitabine. Here, BCL2 is linked to familial pancreatic carcinoma.